rts logo

Bio-Techne Corp (TECH) Stock Could Soon Reward Patient Investors

Bio-Techne Corp (NASDAQ: TECH) is -4.33% lower on its value in year-to-date trading and has touched a low of $51.79 and a high of $85.57 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TECH stock was last observed hovering at around $73.36 in the last trading session, with the day’s gains setting it 0.46%.

Currently trading at $73.82, the stock is -3.05% and -0.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing 0.63% at the moment leaves the stock 0.35% off its SMA200. TECH registered 8.24% gain for a year compared to 6-month gain of 12.67%. The firm has a 50-day simple moving average (SMA 50) of $74.3438 and a 200-day simple moving average (SMA200) of $73.55965.

The stock witnessed a -1.14% loss in the last 1 month and extending the period to 3 months gives it a -7.52%, and is 0.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.94% over the week and 2.90% over the month.

Bio-Techne Corp (TECH) has around 3100 employees, a market worth around $11.71B and $1.16B in sales. Current P/E ratio is 70.67 and Fwd P/E is 34.03. Profit margin for the company is 14.50%. Distance from 52-week low is 42.54% and -13.73% from its 52-week high. The company has generated returns on investments over the last 12 months (6.79%).

with sales reaching $280.26M over the same period.The EPS is expected to grow by 4.56% this year, but quarterly earnings will post 4.80% year-over-year.

Bio-Techne Corp (TECH) Top Institutional Holders

838.0 institutions hold shares in Bio-Techne Corp (TECH), with institutional investors hold 101.21% of the company’s shares. The shares outstanding are 158.22M, and float is at 157.00M with Short Float at 2.24%. Institutions hold 100.17% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 18.18 million shares valued at $1.3 billion. The investor’s holdings represent 11.5581% of the TECH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.99 million shares valued at $1.07 billion to account for 9.5277 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 8.53 million shares representing 5.4198% and valued at over $610.87 million, while STATE STREET CORP holds 4.0054 of the shares totaling 6.3 million with a market value of $451.46 million.

Bio-Techne Corp (TECH) Insider Activity

The most recent transaction is an insider sale by BAUMGARTNER ROBERT V, the company’s Director. SEC filings show that BAUMGARTNER ROBERT V sold 16,000 shares of the company’s common stock on Aug 08 ’24 at a price of $72.10 per share for a total of $1.15 million. Following the sale, the insider now owns 43401.0 shares.

Still, SEC filings show that on May 14 ’24, HIGGINS JOHN L (Director) disposed off 4,000 shares at an average price of $83.84 for $0.34 million. The insider now directly holds 36,608 shares of Bio-Techne Corp (TECH).

Related Posts